Intravitreal Aflibercept Injection for Symptomatic Macular Edema From Retinal Artery Macroaneurysms
Phase of Trial: Phase I
Latest Information Update: 24 Aug 2017
At a glance
- Drugs Aflibercept (Primary)
- Indications Retinal oedema
- Focus Adverse reactions
- 17 Aug 2017 Planned End Date changed from 1 Jun 2017 to 1 Aug 2018.
- 17 Aug 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Aug 2018.
- 06 Jul 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.